Global Sepsis Diagnostic Market Size, Share, Forecast Report, 2020-2027

The report provides rational insights along with historical and forecast data to aid in better understanding of the Global Sepsis Diagnostic Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of the Sepsis Diagnostic market. This study also provides a detailed overview of the opportunities along with the current trends observed in the target market.

The global sepsis diagnostic market size was valued at USD 550.2 million in 2019 and is expected to witness attractive growth over the forecast period. Factors such as high prevalence of sepsis, increasing awareness, and introduction of technologically advanced diagnostic solutions are expected to significantly fuel market growth over the forecast period.

Sepsis is a severe medical condition caused by the overwhelming immune response to an infection. Recent studies have shown an increasing prevalence of this life-threatening disease across the globe. According to the data published by WHO in April 2018, sepsis affects more than 30 million people globally and leads to around 6 million deaths every year. The same source states that globally, around 3 million newborns and 1.2 million children suffer from this condition every year. Such high prevalence is anticipated to increase the demand for diagnostic solutions and drive market growth over the forecast period.

Currently, most of the existing sepsis diagnostic tests can take up to 72 hours to process and provide final results. Thus, a high demand for rapid diagnostic tests exists in the market for early diagnosis of this life-threatening condition that could save thousands of lives. In February 2019, researchers at the University of Strathclyde discovered a cost-effective test for earlier diagnosis of sepsis. This newly developed test uses a microelectrode to analyze the patients’ blood and can provide final results in around two and a half minutes. Key players in the market have lucrative opportunities to strengthen their market position with the development and launch of such advanced rapid tests.

Increasing regulatory approval and the introduction of technologically advanced diagnostic solutions are expected to be the prominent factors facilitating market growth over the forecast period. For instance, in April 2019, Beckman Coulter Inc., a fully owned subsidiary of Danaher Corporation received 510(k) clearance from the U.S. FDA for its Early Sepsis Indicator. This indicator is a cellular biomarker intended to help healthcare professionals to identify patients with sepsis or at high risk of developing the disease. Additionally, in August 2018, Japan-based Sysmex Corporation launched its new HISCL Presepsin Assay Kit, for determining levels of presepsin, the main test parameter for bacterial sepsis. This kit is designed to achieve early diagnosis of bacterial sepsis with high precision as compared to conventional biomarkers.

In June 2018 Sepsis Alliance, a non-profit organization involved “It's About TIME”, a nationwide initiative to spread huge awareness about rapid diagnosis and treatment of the disease. Such initiatives by various organizations are expected to increase the awareness about the disease and increase the demand for its diagnostic solutions. Thus, it is expected to create a lucrative environment for market growth.

Furthermore, hospital-acquired infections (HAIs) can trigger sepsis, especially in the geriatric population, newborn babies, and people suffering from chronic disease. According to the CDC estimates, every year around 1.7 million patients suffer from HAIs and around 99,000 patients die due to HAIs in U.S. Hence, increase in the prevalence of HAIs is anticipated to raise demand for diagnostic solutions for the disease and drive the market for sepsis diagnostics over the forecast period.

The report covers major players operating in the market along with the key strategies implemented to achieve a competitive edge against a majority of the vendors which provides a competitive outlook of the industry. The competitive landscape further includes details about different players and their position on a global and a local level is also explained in detail in this compiled study. These insights were prepared through mapping business strategies and products that offer high revenue generation capacities. Key players of the global Sepsis Diagnostic market are included as given below:

Some of the key players operating in this space comprise Becton, Dickinson and Company; bioMérieux SA; Sysmex Corporation; F. Hoffmann-La Roche AG; Beckman Coulter, Inc.; Thermo Fisher Scientific, Inc.; Cepheid Inc.; Bruker Corporation; and Nanosphere, Inc.

The key players operating in the market are adopting inorganic growth strategies such as mergers and partnerships in order to penetrate new regions and provide access of its solutions into vast geography. For instance, in December 2019, U.S.-based Ontera, Inc. and England-based QuantuMDx Group Limited entered into a strategic collaboration for the development of advanced sepsis diagnostic solutions.

The global Sepsis Diagnostic market has been segmented as below:

• Product Outlook (Revenue, USD Million, 2016 - 2027)
  • Instruments
    • Microbiology
    • Molecular Diagnostics
    • Immunoassays
    • Flow Cytometry
  • Blood Culture Media
    • Microbiology
    • Molecular Diagnostics
    • Immunoassays
    • Flow Cytometry
  • Assay Kits and Reagents
    • Microbiology
    • Molecular Diagnostics
    • Immunoassays
    • Flow Cytometry
  • Software
    • Microbiology
    • Molecular Diagnostics
    • Immunoassays
    • Flow Cytometry
  • Technology Outlook (Revenue, USD Million, 2016 - 2027)
    • Microbiology
    • Molecular Diagnostics
    • Immunoassays
    • Flow Cytometry
  • Pathogen Outlook (Revenue, USD Million, 2016 - 2027)
    • Bacterial Sepsis
      • Gram-Positive Bacteria
      • Gram-Negative Bacteria
    • Fungal Sepsis
    • Others
  • Testing Type Outlook (Revenue, USD Million, 2016 - 2027)
    • Laboratory Testing
    • PoC Testing

• Global Sepsis Diagnostic Market by Region
• North America
• Europe
• Asia Pacific
• Rest of the World

Reasons to Purchase this Report:

Estimates Sepsis Diagnostic development trends with SWOT analysis

• Detailed business profiles including product offerings, recent developments, key financial information, and strategies employed by main market players
• Analysis of various regions and countries that includes the demand and supply based actions, which consequently have a major influence on the market’s expansion
• Market dynamics scenario, along with growth opportunities for players in the years to come
• Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the mentioned forecast period
• Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects